- Home
- HYPR vs CGO Comparison
HYPR vs CGO Comparison
Compare HYPR & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HYPR | CGO |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 114.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HYPR | CGO |
|---|---|---|
| Price | $0.94 | $11.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.28 | N/A |
| AVG Volume (30 Days) | ★ 475.0K | 34.7K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.25% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,591,000.00 | N/A |
| Revenue This Year | $12.80 | N/A |
| Revenue Next Year | $36.09 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.53 | $7.90 |
| 52 Week High | $2.22 | $10.93 |
Technical Indicators
Market Signals| Indicator | HYPR | CGO |
|---|---|---|
| Relative Strength Index (RSI) | 36.64 | 39.20 |
| Support Level | $1.00 | $10.87 |
| Resistance Level | $1.18 | $11.38 |
| Average True Range (ATR) | 0.10 | 0.18 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 3.55 | 34.74 |
Price Performance
Historical ComparisonAbout HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.